跳至主要内容
临床试验/CTRI/2023/02/049819
CTRI/2023/02/049819尚未招募未知

ntapped Neuroimaging tools for neuro-oncology: Connectomics

BrainSight Technology Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Brain tumors scheduled for surgical and/ or radiation therapy
  • 18 to 59 years

排除标准

  • Anyone <18 years of age or anybody >60 years
  • History of primary neurological disorders including seizure disorders/pre-existing disorders of development and degenerative disorders involving structural changes
  • Primary/pre-existing development and degenerative disorder involving structural changes
  • Primary/pre-existing Movement, Vision and speech disorders
  • Follow-up cases
  • Tumor relapses
  • Patients with contraindications to MRI scanning
  • Pregnant women
  • Cases of meningioma and extra-axial tumors

研究者

发起方
BrainSight Technology Pvt. Ltd.

相似试验

Functional Connectomics for Brain Tumour Surgery: A... | 临床试验